ELOXX PHARMACEUT

ELOX NASDAQ
5.99
-0.49
-7.56%
After Hours: 5.99 0 0.00% 16:00 08/23 EDT
Open
6.47
Prev Close
6.48
High
6.59
Low
5.94
Volume
54.41K
Avg Vol (3M)
91.26K
52 Week High
18.50
52 Week Low
5.14
% Turnover
0.14%
Market Cap
239.24M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ELOXX PHARMACEUT ELOX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing ribonucleic acid (RNA)-modulating drug candidates, which are designed to be eukaryotic ribosomal selective glycosides (ERSG). It is developing its drug candidates for treating rare and ultra-rare premature stop codon diseases. ELX-02 is its lead investigational drug product candidate. ELX-02 is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. Its preclinical candidate pool consists of a library of novel ERSG drug candidates identified based on read-through potential and cytoplasmic ribosomal selectivity.
MORE >

Recently

Name
Price
%Change